glp-1 prices drop Novo Slashes List Prices! Downsized News GLP-1 costs rise, but there

While demand remains exceptionally high, Lilly's expanded capacity for Mounjaro and Zepbound (both GLP-1 drugs indirectly supported by this investment) could challenge Novo Nordisk's market share, especially if Novo Nordisk experiences its own supply constraints or if Lilly achieves superior efficiency and availability

J.TianY

The information in this article is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment

In humans and other mammals, the liver is the major site of expression of xenobioticmetabolising enzymes, but extrahepatically localized enzymes also appear to be of great importance